Logo
J

Jennison Associates LLC

431 employees

Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969.

Investor insights

Sectors invested in

Biotechnology18
Health Care15
Therapeutics11
Medical6
Pharmaceutical5
Genetics4
Biopharma3
Oncology3
Life Science2
Health Diagnostics2
Medical Device2
Oncology and Network Biology2
Orphan and Ultra-orphan Disorders1
Anti-infectives1
Sickle Cell Disease1
Blood Diseases1
Transfusion-Dependent Beta Thalassemia1
Rare Diseases1
Ocular Medicines1
Immunogenetics1

Funding rounds participated in

$65M sweet spot round size

Most of their 26 investments are in rounds between $51M and $77M

Investor type

Investment Bank
Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services
Venture Capital

Date founded

1969

Investments made

E

ELMS: Electric Last Mile Solutions raised $155M on June 28, 2021

Investors: Jennison Associates LLC

T

Talkspace raised $300M on June 23, 2021

Investors: Woodline Partners LP and Jennison Associates LLC

F

Field Trip Health raised $76M on March 17, 2021

Investors: Soleus Capital Management, L.P., Avidity Partners, Pura Vida Investments, Sphera Fund and Jennison Associates LLC

U

Undisclosed raised $400M on January 8, 2021

Investors: Perceptive Advisors, Senator Investment Group LP and Jennison Associates LLC

U

Undisclosed raised $120M on September 7, 2018

Investors: Surveyor Capital, Perceptive Advisors, T. Rowe Price and Jennison Associates LLC

S

Syndax Pharmaceuticals raised $80M on August 24, 2015

Investors: Delos Capital, Forward Ventures, RMI Partners, MPM Capital, Domain Associates, OrbiMed Advisors and Jennison Associates LLC

W

Wave Life Sciences raised $66M on August 18, 2015

Investors: New Leaf Venture Partners, Redmile Group, Foresite Capital, RA Capital Management, L.P. and Jennison Associates LLC

O

Ovid Therapeutics raised $75M on August 11, 2015

Investors: Sanofi Ventures, Tekla Capital Management, Sphera Fund, Redmile Group and Jennison Associates LLC

E

Editas Medicine raised $120M on August 10, 2015

Investors: Omega Funds, Third Rock Ventures, Khosla Ventures, GV, Flagship Ventures, Viking Global Investors, Polaris Partners, Innova Capital, T. Rowe Price and Jennison Associates LLC

G

GenSight Biologics raised $36M on July 23, 2015

Investors: HealthCap, Index Ventures, Sphera Fund, Abingworth, Perceptive Advisors, Versant Ventures and Jennison Associates LLC

FAQ